Aberdeen Group Portfolio holdings
Aberdeen Group is a British wealth and investment company, created in 2017 when Standard Life merged with Aberdeen Asset Management. In 2018 it agreed to sell the Standard Life insurance business to Phoenix Group, shifting the company from insurance toward asset management. After selling the Standard Life name to Phoenix Group in 2021 it rebranded as abrdn, a vowel-free name that drew criticism, and in 2025 it went back to Aberdeen. Among its businesses is Interactive Investor, a British retail investing service that runs on subscriptions, which it bought in 2022.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$319M |
| 2 |
Amazon
AMZN
|
+$165M |
| 3 |
Microsoft
MSFT
|
+$110M |
| 4 |
HONA
Honeywell Aerospace
HONA
|
+$92.7M |
| 5 |
UnitedHealth
UNH
|
+$69.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$182M |
| 2 |
RTX Corp
RTX
|
+$97.9M |
| 3 |
Marvell Technology
MRVL
|
+$81.2M |
| 4 |
GE Vernova
GEV
|
+$80.7M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$73.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.75% |
| 2 | Healthcare | 12.68% |
| 3 | Consumer Discretionary | 10.96% |
| 4 | Communication Services | 10.76% |
| 5 | Financials | 9.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
301
Structure Therapeutics
GPCR
$1.36B
| $34.3M | 0.05% |
639,915
+248,106
| +63% | +$11M |
2024 Q2
8 quarters
|
|
302
Brixmor Property Group
BRX
$9.28B
| $34.3M | 0.05% |
1,088,543
+12,018
| +1% | +$367K |
2017 Q3
35 quarters
|
|
303
Host Hotels & Resorts
HST
$16.9B
| $34.3M | 0.05% |
1,445,438
+427,050
| +42% | +$9.5M |
2017 Q3
35 quarters
|
|
304
Rivian
RIVN
$19.4B
| $34.3M | 0.05% |
1,974,727
+280,873
| +17% | +$4.38M |
2021 Q4
18 quarters
|
|
305
Dyne Therapeutics
DYN
$3.24B
| $34.2M | 0.05% |
1,539,434
+109,050
| +8% | +$2.03M |
2024 Q4
6 quarters
|
|
306
Encompass Health
EHC
$13.8B
| $34.1M | 0.05% |
337,839
| – | – |
2024 Q4
6 quarters
|
|
307
Casey's General Stores
CASY
$24.9B
| $34.1M | 0.05% |
42,875
-16,041
| -27% | -$12.9M |
2024 Q3
7 quarters
|
|
308
Fifth Third Bancorp
FITB
$48.3B
| $33.9M | 0.05% |
601,179
+33,875
| +6% | +$1.72M |
2017 Q3
35 quarters
|
|
309
American International
AIG
$42.4B
| $33.5M | 0.05% |
449,008
+11,093
| +3% | +$843K |
2017 Q3
35 quarters
|
|
310
ARS Pharmaceuticals
SPRY
$264M
| $33.4M | 0.05% |
4,170,629
+57,012
| +1% | +$490K |
2025 Q1
5 quarters
|
|
311
Immunovant
IMVT
$5.86B
| $33M | 0.05% |
857,030
-303,732
| -26% | -$9.25M |
2023 Q4
10 quarters
|
|
312
TotalEnergies
TTE
$195B
| $32.8M | 0.05% |
421,800
+62,860
| +18% | +$5.56M |
2017 Q3
35 quarters
|
|
313
Camden Property Trust
CPT
$12B
| $32.7M | 0.05% |
285,499
+22,274
| +8% | +$2.37M |
2018 Q2
32 quarters
|
|
314
Royalty Pharma
RPRX
$30.1B
| $32.4M | 0.05% |
578,201
+4,455
| +0.8% | +$232K |
2020 Q4
22 quarters
|
|
315
Teledyne Technologies
TDY
$29.3B
| $32.3M | 0.05% |
48,459
+5,756
| +13% | +$3.63M |
2019 Q4
26 quarters
|
|
316
PayPal
PYPL
$49B
| $32.1M | 0.05% |
743,536
+833
| +0.1% | +$37.9K |
2017 Q3
35 quarters
|
|
317
Disc Medicine
IRON
$3.7B
| $32M | 0.05% |
438,174
+62,560
| +17% | +$4.3M |
2025 Q2
4 quarters
|
|
318
Republic Services
RSG
$74.8B
| $31.7M | 0.04% |
148,837
+17,618
| +13% | +$3.68M |
2017 Q3
35 quarters
|
|
319
SharkNinja
SN
$30.6B
| $31.6M | 0.04% |
207,702
-18,395
| -8% | -$2.2M |
2024 Q2
8 quarters
|
|
320
Vericel Corp
VCEL
$2.33B
| $31.6M | 0.04% |
710,238
+26,113
| +4% | +$940K |
2025 Q2
4 quarters
|
|
321
Advanced Drainage Systems
WMS
$10.9B
| $31.6M | 0.04% |
201,310
-4,415
| -2% | -$631K |
2021 Q4
18 quarters
|
|
322
Valero Energy
VLO
$98B
| $31.5M | 0.04% |
121,051
+5,979
| +5% | +$1.47M |
2017 Q3
35 quarters
|
|
323
Cohu
COHU
$1.65B
| $31.5M | 0.04% |
+426,149
| New | +$21.3M |
2026 Q2
0 quarters
|
|
324
Block Inc
XYZ
$50.8B
| $31.4M | 0.04% |
413,403
+345
| +0.1% | +$24.3K |
2018 Q2
32 quarters
|
|
325
GeneDx Holdings
WGS
$1.92B
| $31.4M | 0.04% |
457,201
+227,105
| +99% | +$12.9M |
2026 Q1
1 quarter
|
|
Similar funds
Aberdeen Group's Q2 2026 Portfolio in Review
As of Q2 2026, Aberdeen Group held 978 positions worth $71.2B, up 15% from $61.9B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Aberdeen Group's Q2 2026 filing shows 47 new, 453 increased, 412 reduced and 44 closed positions. Its largest new stake was Honeywell Aerospace: 420,093 shares worth $92.9M. The largest sale was Honeywell, an estimated $182M.
By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 31% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Aberdeen Group's largest Q2 2026 buy was Honeywell Aerospace: 420,093 shares worth $92.9M.
- Aberdeen Group added most to Tesla in Q2 2026, an estimated $319M increase.
- Aberdeen Group's biggest Q2 2026 reduction was RTX Corp, cutting an estimated $97.9M.
- Aberdeen Group fully exited Honeywell in Q2 2026, selling an estimated $182M.
- Aberdeen Group's ten largest holdings make up 37% of its $71.2B portfolio in Q2 2026.
- Aberdeen Group opened 47 new positions and closed 44 in Q2 2026.
- Aberdeen Group's portfolio value rose 15% quarter-over-quarter to $71.2B.
Based on Aberdeen Group's 13F filing for Q2 2026, filed 31 Jul 2026.